3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
2
Pain
2
Lung Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Agnosia
2
Urinary Bladder Neoplasms
1
Sarcoma
1
Respiratory Aspiration
1
Respiration Disorders
1
Rectal Neoplasms
1
Rare Diseases
1
Postoperative Nausea and Vomiting
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Pleural Diseases
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Neoplasms
1
Malignant Neoplasm of Abdomen
1
Hyperalgesia
1
Female Breast Cancer
1
Diverticulosis, Colonic
1
Carcinoma, Hepatocellular
1
Breast Diseases
1
Interventions
Dexamethasone
2
phenazine
1
esmolol
1
Surveys and Questionnaires
1
Sufentanil
1
Promethazine
1
Postoperative Care
1
Ondansetron
1
Fentanyl
1
Famotidine
1
Electroacupuncture
1
Electric Stimulation Therapy
1
Electric Stimulation
1
Diphenhydramine
1
Dexmedetomidine
1
Calcium Dobesilate
1
Antiemetics
1
Anesthesia, General
1
Anesthesia
1
Adrenergic beta-Antagonists
1
Acupuncture Therapy
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Postoperative Nausea and Vomiting
×
Fentanyl
×
Clear all
NCT01544959
2018-10-24
PAINFree
Université de Sherbrooke
Phase NA
Completed
84 enrolled